Procept Biorobotics Corp stock is traded at $24.70, with a volume of 1,037,263. It is down -4.08% in the last 24 hours and up +31.24% over the past month. PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
Previous Close:
$25.75
Open:
$25.50
24h Volume:
1,037,263
Relative Volume:
0.72
Market Cap:
$1.42B
Revenue:
$322.02M
Net Income/Loss:
-$102.47M
P/E Ratio:
-
EPS:
-$1.83
Net Cash Flow:
-$80.57M
1W Performance:
+3.78%
1M Performance:
+31.24%
6M Performance:
-12.13%
1Y Performance:
-11.44%
1-Day Range:
$24.64$26.54
1-Week Range:
$23.03$26.54
52-Week Range:
$16.67$38.11
Procept Biorobotics Corp Stock (PRCT) Company Profile
Name
Procept Biorobotics CorpSector
HealthcareIndustry
Medical DevicesPhone
(650) 232-9832Address
150 BAYTECH DRIVE, SAN JOSE, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS